Puma Biotechnology Director Sells 77,748 Shares as Q1 Results Show Mixed Signals
Puma Biotechnology director Troy Wilson sold 77,748 shares under a 10b5-1 plan amid recent RSU vesting. We break down the trade, Q1 2026 miss, and valuation view.
Puma Biotechnology Director Sells 77,748 Shares as Q1 Results Show Mixed Signals Read More »










